通過使用能減低黑皮質素4受體活性的試劑以治療帕金遜疾病或帕金遜綜合症

• 收藏
• 分享

专利权人:

NEURONOVA AB

发明人:

LINDQUIST, PER,BERTILSSON, GORAN,MERCER, ALEX,PATRONE, CESARE,WIKSTROM, LILIAN,ZACHRISSON, OLOF

申请号：

HK09109942.1

公开号：

HK1130018B

申请日:

2009.10.28

申请国别(地区):

HK

年份:

2013

代理人:

摘要：

Novel methods are provided for modulating CNS cell neogenesis in the CNS cells in vitro or in vivo, involving the use of agents that decrease the activity of the melanocortin 4 receptor (MC4R). When the methods of the invention are applied to a subject such as a human, it may be used for reducing a symptom of a CNS disorder.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/